Cryobiopsy with endobronchial ultrasonography using a guide sheath for peripheral pulmonary lesions and DNA analysis by next generation sequencing and rapid on-site evaluation.


Journal

Respiratory investigation
ISSN: 2212-5353
Titre abrégé: Respir Investig
Pays: Netherlands
ID NLM: 101581124

Informations de publication

Date de publication:
Mar 2019
Historique:
received: 12 06 2018
revised: 10 10 2018
accepted: 23 10 2018
pubmed: 25 11 2018
medline: 8 6 2019
entrez: 25 11 2018
Statut: ppublish

Résumé

The purpose of this study was to evaluate the diagnostic accuracy of Cryo with endobronchial ultrasonography using a guide sheath (EBUS-GS) for peripheral pulmonary lesions (PPLs) to assess the volume of specimen, determine DNA sequencing analysis, and evaluate the utility of rapid on-site evaluation (ROSE). Out of 30 patients assessed for eligibility, 23 were enrolled in this prospective study. The histological diagnostic yield of Cryo was evaluated and the volume was compared to that of trans-bronchial biopsy (TBB). DNA analysis of Cryo was performed using next generation sequencing (NGS). ROSE was compared with the final diagnosis. The sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and diagnostic accuracy rate was 85%, 100%, 100%, 50%, 87% for Cryo and 80%, 100%, 100%, 42.9%, 82.6% for TBB, respectively. The mean volume was 0.078 cm Cryo with EBUS-GS for PPLs is a safe and potentially useful diagnostic strategy. It has a high diagnostic yield, and provides significantly larger specimens than TBB. It also provides high quantity and quality of DNA for NGS and high concordance rate between ROSE and the final diagnosis.

Sections du résumé

BACKGROUND BACKGROUND
The purpose of this study was to evaluate the diagnostic accuracy of Cryo with endobronchial ultrasonography using a guide sheath (EBUS-GS) for peripheral pulmonary lesions (PPLs) to assess the volume of specimen, determine DNA sequencing analysis, and evaluate the utility of rapid on-site evaluation (ROSE).
METHODS METHODS
Out of 30 patients assessed for eligibility, 23 were enrolled in this prospective study. The histological diagnostic yield of Cryo was evaluated and the volume was compared to that of trans-bronchial biopsy (TBB). DNA analysis of Cryo was performed using next generation sequencing (NGS). ROSE was compared with the final diagnosis.
RESULTS RESULTS
The sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and diagnostic accuracy rate was 85%, 100%, 100%, 50%, 87% for Cryo and 80%, 100%, 100%, 42.9%, 82.6% for TBB, respectively. The mean volume was 0.078 cm
CONCLUSIONS CONCLUSIONS
Cryo with EBUS-GS for PPLs is a safe and potentially useful diagnostic strategy. It has a high diagnostic yield, and provides significantly larger specimens than TBB. It also provides high quantity and quality of DNA for NGS and high concordance rate between ROSE and the final diagnosis.

Identifiants

pubmed: 30470645
pii: S2212-5345(18)30111-4
doi: 10.1016/j.resinv.2018.10.006
pii:
doi:

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

150-156

Informations de copyright

Copyright © 2018 The Japanese Respiratory Society. Published by Elsevier B.V. All rights reserved.

Auteurs

Ken Arimura (K)

Department of Respiratory Medicine, Tokyo Women׳s Medical University, Tokyo, Japan; Division of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA. Electronic address: arimuraken@gmail.com.

Etsuko Tagaya (E)

Department of Respiratory Medicine, Tokyo Women׳s Medical University, Tokyo, Japan.

Hiroyuki Akagawa (H)

Tokyo Women׳s Medical University Institute for Integrated Medical Sciences, Tokyo, Japan.

Yoji Nagashima (Y)

Department of Surgical Pathology, Tokyo Women׳s Medical University, Tokyo, Japan.

Satoru Shimizu (S)

Department of Medical Education, Tokyo Women׳s Medical University School of Medicine, Tokyo, Japan.

Yoshihide Atsumi (Y)

Department of Respiratory Medicine, Tokyo Women׳s Medical University, Tokyo, Japan.

Akitoshi Sato (A)

Department of Respiratory Medicine, Tokyo Women׳s Medical University, Tokyo, Japan.

Masato Kanzaki (M)

Department of Thoracic Surgery, Tokyo Women׳s Medical University, Tokyo, Japan.

Mitsuko Kondo (M)

Department of Respiratory Medicine, Tokyo Women׳s Medical University, Tokyo, Japan.

Kiyoshi Takeyama (K)

Department of Respiratory Medicine, Tokyo Women׳s Medical University, Tokyo, Japan.

Pierre P Massion (PP)

Division of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA.

Jun Tamaoki (J)

Department of Respiratory Medicine, Tokyo Women׳s Medical University, Tokyo, Japan.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH